SCND
Scientific Industries, Inc.0.5530
+0.0130+2.41%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
6.60MP/E (TTM)
-Basic EPS (TTM)
-0.07Dividend Yield
0%Recent Filings
8-K
Auditor switch completed cleanly
Scientific Industries dismissed Berkowitz Pollack Brant Advisors + CPAs as its auditor on January 14, 2026, after Carr, Riggs & Ingram acquired BPB's capital markets practice effective January 1. The Audit Committee approved CRI as the new independent auditor. No disagreements or reportable events occurred. Smooth transition.
10-Q
Q3 FY2025 results
Scientific Industries posted Q3 revenues of $1.4M, up 5% y/y from $1.3M yet down q/q as Genie sales ended post-August 7 divestiture to Troemner for $9.6M cash (net $7.6M proceeds after adjustments), booking $5.3M gain that flipped continuing operations to $4.0M profit versus $1.5M loss last year. Gross margin slipped to 45.5% from 51.0% on fixed costs and tariffs, while op expenses fell 4% y/y to $2.2M, led by Bioprocessing cuts; Torbal drove revenue growth to $1.1M. Cash climbed to $1.2M, investments to $7.1M, no debt. Cash burn persisted at $4.4M YTD from ops. One customer topped 10% of sales. Bioprocessing softness lingers.
8-K
Auditor switch, new CFO
Scientific Industries dismissed Forvis Mazars as auditor and appointed Berkowitz Pollack Brant for Q3 2025 onward—no disagreements or reportable events noted. It also named Zachary Rovinsky CFO on August 22, 2025, replacing interim Helena Santos, with $200,000 salary and 10% target bonus. Clean switch. Leadership bolsters finance expertise amid audit refresh.
10-Q
Q2 FY2025 results
Scientific Industries posted Q2 revenues of $2.3M, down 12.0% y/y from $2.6M yet stable q/q, with gross margin slipping to 43.8% from 48.8% on tariff-driven material costs in Benchtop Lab (90% of sales). Operating loss widened to $1.5M from $1.3M y/y, driven by Bioprocessing Systems' $1.5M shortfall, but G&A fell 8.1% post headcount cuts. Cash climbed to $891K on $1.5M stock raise; operating cash burn hit $2.8M YTD. Diluted EPS of -$0.13 aligns with 10.9M shares (derived). Agreed August 7 to sell Genie assets for $9.6M plus $1.5M earnout. Customer concentration risks linger.
8-K
Sells Genie assets for $9.6M
IPO
Employees
Sector
Industry
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
HBIO
Harvard Bioscience, Inc.
0.70-0.00
MLAB
Mesa Laboratories, Inc.
78.63+0.80
MLSS
Milestone Scientific, Inc.
0.37+0.02
MTD
Mettler-Toledo International, I
1386.45-26.02
RSCF
Reflect Scientific, Inc.
0.05+0.00
SHMXY
-
16.77+0.00
SOAGY
Sartorius AG
56.43-0.16
SOTK
Sono-Tek Corporation
3.70+0.10
TMO
Thermo Fisher Scientific Inc
570.16-5.75